FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

cafead

Administrator
Staff member
  • cafead   May 30, 2018 at 09:02: PM
via A Vertex Pharmaceuticals partnership with CRISPR Therapeutics to test a genetically engineered drug in patients as a treatment for sickle cell disease has been dealt a setback.

article source